07th January 2025
Federal funding for TRI-based researchers
Researchers share in NHMRC grants for projects in cancer, antimicrobial resistance, abnormal bone formation and eczema.
Latest News
10 May 2021
FDA approval for new saliva oral and throat cancer diagnostic
Research by TRI-affiliated A/Prof Chamindie Punyadeera has led to the commercialisation of a new diagnostic.
More about FDA approval for new saliva oral and throat cancer diagnostic
16 April 2021
Potential New Treatment Could Help Save COVID-19 Patients
Anti-inflammatory drug, IC14, enters Phase II clinical trial to treat severely ill COVID-19 patients.
More about Potential New Treatment Could Help Save COVID-19 Patients
25 March 2021
US Department of Defense breast cancer grant
Dr Fernando Guimaraes has been awarded US$750K to progress a new breast cancer treatment
More about US Department of Defense breast cancer grant 
24 March 2021
Breakthrough therapy cures lymphoma patient
A Mater Research team has cured a patient of a rare type of lymphoma
More about Breakthrough therapy cures lymphoma patient
24 March 2021
Anticancer and Antimicrobial peptide treatments
QUT's Dr Sónia Henriques, is developing selective and potent anticancer peptide-based treatments.
More about Anticancer and Antimicrobial peptide treatments 
22 March 2021
New funding for COVID-19 research
Mater Research's TRI-based Dr Mitchell Sullivan has received funding for a COVID-19 research project.
More about New funding for COVID-19 researchPages
Events
Sorry, no results found
Please try again with less restrictive search criteria
Upcoming Events
Sorry, no results found
Please try again with less restrictive search criteria
